Literature DB >> 10385237

Neuropeptide Y is a prejunctional inhibitor of vagal but not sympathetic inotropic responses in guinea-pig isolated left atria.

A P Serone1, J A Angus.   

Abstract

1. The effects of NPY and related peptides were examined on basal contractile force and nerve-mediated inotropic responses to electrical field stimulation of the guinea-pig isolated left atrium. 2. Electrical field stimulus (EFS)-inotropic response curves were constructed by applying 1-64 trains of four field pulses (200 Hz, 0.1 ms duration, 100 V) across isolated left atria (paced at 4 Hz, 2 ms, 1-4 V) within the atrial refractory period. Curves were constructed in presence of vehicle, propranolol (1 microM) or atropine (1 microM) to determine appropriate stimulus conditions. 3. The effects of PYY (1-10,000 nM), NPY (0.01-10 microM), N-Ac-[Leu28,31]NPY(24-36) (N-A[L]NPY(24-36); 0.01-10 microM) and clonidine (0.1-1000 nM) were examined on the positive and negative inotropic responses to EFS (eight trains, four pulses per refractory period). 4. NPY-related peptides had no effect on basal force of contraction nor on the inotropic concentration-response curves to bethanechol or isoprenaline. All three peptides inhibited vagally-mediated negative inotropic responses; rank order of potency PYY>NPY> or =N-A[L]NPY(24-36) was consistent with an action at prejunctional Y2-receptors. Clonidine concentration-dependently inhibited sympathetic inotropic responses. However, PYY, NPY and N-A[L]NPY(24-36) failed to mediate any significant inhibition of the positive inotropic response to EFS. 5. These data demonstrate that NPY is an effective inhibitor of vagal but not sympathetically-mediated inotropic responses in the guinea-pig isolated left atria. This may suggest that endogenously co-released NPY is important in mediating cross talk between efferent components of the autonomic nervous system modulating cardiac contractility, acting overall to sustain positive inotropic responses.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10385237      PMCID: PMC1566037          DOI: 10.1038/sj.bjp.0702565

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  36 in total

1.  Modulation by adrenergic transmitters of the efferent function of capsaicin-sensitive nerves in cardiac tissue.

Authors:  S Amerini; A Rubino; S Filippi; F Ledda; L Mantelli
Journal:  Neuropeptides       Date:  1991-12       Impact factor: 3.286

Review 2.  Receptors for neuropeptide Y: multiple subtypes and multiple second messengers.

Authors:  M C Michel
Journal:  Trends Pharmacol Sci       Date:  1991-10       Impact factor: 14.819

Review 3.  Repeated measurements and multiple comparisons in cardiovascular research.

Authors:  J Ludbrook
Journal:  Cardiovasc Res       Date:  1994-03       Impact factor: 10.787

4.  Characterization of neuropeptide Y binding sites in rat cardiac ventricular membranes.

Authors:  A Balasubramaniam; S Sheriff; D F Rigel; J E Fischer
Journal:  Peptides       Date:  1990 May-Jun       Impact factor: 3.750

5.  Adrenoreceptor-mediated effect of neuropeptide Y decreases cardiac inotropic responses.

Authors:  N D Woo; D S Lam; J A Hays; V Panagia; P K Ganguly
Journal:  Biochim Biophys Acta       Date:  1994-07-21

6.  Neuropeptide Y prevents agonist-stimulated increases in contractility.

Authors:  N D Woo; P K Ganguly
Journal:  Hypertension       Date:  1995-09       Impact factor: 10.190

7.  Differential inhibition of neuropeptide Y on the chronotropic and inotropic responses to sympathetic and parasympathetic stimulation in the isolated, perfused dog atrium.

Authors:  L M Ren; Y Furukawa; Y Karasawa; M Murakami; M Takei; M Narita; S Chiba
Journal:  J Pharmacol Exp Ther       Date:  1991-10       Impact factor: 4.030

8.  A novel neuropeptide Y analog, N-acetyl [Leu28,Leu31]neuropeptide Y-(24-36), with functional specificity for the presynaptic (Y2) receptor.

Authors:  E K Potter; J A Barden; M J McCloskey; L A Selbie; A Tseng; H Herzog; J Shine
Journal:  Eur J Pharmacol       Date:  1994-05-17       Impact factor: 4.432

9.  Effect of neuropeptide Y on isolated rat hearts.

Authors:  S R Jolly; A Ordoukhani; A Movahed
Journal:  Pharmacology       Date:  1991       Impact factor: 2.547

10.  The effects of neuropeptide Y on myocardial contractility and coronary blood flow.

Authors:  S J Awad; R Einstein; E K Potter; D P Richardson
Journal:  Br J Pharmacol       Date:  1991-09       Impact factor: 8.739

View more
  3 in total

1.  Role of N-type calcium channels in autonomic neurotransmission in guinea-pig isolated left atria.

Authors:  A P Serone; J A Angus
Journal:  Br J Pharmacol       Date:  1999-06       Impact factor: 8.739

2.  Neuropeptide Y inhibits acetylcholine release in human heart atrium by activation of Y2-receptors.

Authors:  Eckhard Schwertfeger; Thomas Klein; Oliver Vonend; Vitus Oberhauser; Johannes Stegbauer; Lars Christian Rump
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2004-04-22       Impact factor: 3.000

3.  Neuropeptide Y and gamma-melanocyte stimulating hormone (gamma-MSH) share a common pressor mechanism of action.

Authors:  Kenneth A Gruber; Wei Fan; Helena Akerberg; Dan Larhammar; Melissa J S Chee; William F Colmers; Roger D Cone
Journal:  Endocrine       Date:  2009-04-11       Impact factor: 3.633

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.